Drug testing without the pain

Press/Media: Research


Dr Aaron Brady, a clinical pharmacist in Dr Donnelly’s group, is currently conducting the first clinical evaluation of the technology using caffeine as a model drug (though he admits that finding caffeine-free volunteers for the control group can be hard). Eyman Eltayib, a PhD student with the group, is also trialling the technique for blood-free glucose sampling at her home university in Khartoum, Sudan. Future targets for sampling could include, for example, therapeutic drugs where monitoring the correct dose can be important

Engineering and Physical Sciences Research Council

Reference: PN 82-13



Period02 Dec 2013

Media coverage


Media coverage

  • TitleDrug testing without the pain
    PersonsAaron Brady


  • clinical pharmacy
  • therapeutic drug monitoring
  • HPLC